A review for natural polysaccharides with anti-pulmonary fibrosis properties, which may benefit to patients infected by 2019-nCoV

Pulmonary fibrosis (PF) is a lung disease with highly heterogeneous and mortality rate, but its therapeutic options are now still limited. Corona virus disease 2019 (COVID-19) has been characterized by WHO as a pandemic, and the global number of confirmed COVID-19 cases has been more than 8.0 millio...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Rui-rong, Li, Ya-jun, Chen, Jun-jia, Lu, Chuan-li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7340049/
https://www.ncbi.nlm.nih.gov/pubmed/32829859
http://dx.doi.org/10.1016/j.carbpol.2020.116740

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7340049/
https://www.ncbi.nlm.nih.gov/pubmed/32829859
http://dx.doi.org/10.1016/j.carbpol.2020.116740

Ejemplares similares